Ellen Mona Gratia Wilcke
Vorstandsvorsitzender bei Stockholms universitet Inkubator AB
Profil
Ellen Mona Gratia Wilcke is the founder of Glucox Biotech AB, which was founded in 2003.
Currently, Dr. Wilcke holds the position of Chief Executive Officer at Stockholms universitet Inkubator AB since 2007, and is also the Chairman of AB svenska stjärnor.
Additionally, Dr. Wilcke is a Director at Satila Medtech AB, Neozeo AB, and TIRmed Pharma AB.
Formerly, Dr. Wilcke held positions as Director at Redoxis AB and ProNoxis AB, Deputy Director at Brighter AB, and Principal at Pharmacia Corp.
and Accuro Immunology AB.
Dr. Wilcke obtained a doctorate degree from the University of Stockholm.
Aktive Positionen von Ellen Mona Gratia Wilcke
| Unternehmen | Position | Beginn |
|---|---|---|
| Satila Medtech AB | Direktor/Vorstandsmitglied | - |
| Stockholms universitet Inkubator AB | Vorstandsvorsitzender | 01.01.2007 |
TIRmed Pharma AB
 TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology TIRmed Pharma AB is engaged in pharmacy services. The company was founded by Jan-Erik Nystroem and Anna-Lena Spetz in 2018 and is headquartered in Bromma, Sweden. | Direktor/Vorstandsmitglied | - |
AB svenska stjärnor
 AB svenska stjärnor Investment ManagersFinance AB svenska stjärnor is an asset management company based in Linköping, Sweden. AB svenska stjärnor provides asset management services. The Swedish company was founded in 2018. | Vorsitzender | - |
Neozeo AB
 Neozeo AB Information Technology ServicesTechnology Services Neozeo AB develops blockchain technology. The company is based in Stockholm, Sweden. and has subsidiaries in Latvia. The Swedish company was founded in 2010. The CEO is Petr Vasiliev. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Ellen Mona Gratia Wilcke
| Unternehmen | Position | Ende |
|---|---|---|
Glucox Biotech AB
 Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Gründer | - |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Direktor/Vorstandsmitglied | - |
| BRIGHTER AB (PUBL) | Corporate Officer/Principal | - |
Redoxis AB
 Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Ellen Mona Gratia Wilcke
| University of Stockholm | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BRIGHTER AB (PUBL) | Technology Services |
| Private Unternehmen | 10 |
|---|---|
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Accuro Immunology AB
 Accuro Immunology AB Pharmaceuticals: MajorHealth Technology Accuro Immunology AB develops and manufactures active immunotherapy products. The firm's products help to treat the patients suffering from problems with immune escape/evasion. The company was founded by Peter Gunnar Maurits Wolpert and Elisabeth Wolpert in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Glucox Biotech AB
Glucox Biotech AB Pharmaceuticals: MajorHealth Technology Glucox Biotech AB is a holding company. It develops clinically applicable therapeutics for treatment of type 2 diabetes; hyperglycaemia, insulin resistance and resulting complications. The firm explores new ideas for the prevention of cellular damage in ischemic stroke and heart infarction, as well the idea behind Glucox Biotech's therapies is to reduce oxidative stress by preventing the intracellular formation of reactive oxygen species. The company was founded by Ellen Mona Gratia Wilcke and Per Ingvar O. Wikström on July 1, 2003 and is headquartered in Stockholm, Sweden. | Health Technology |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
| Satila Medtech AB | |
Neozeo AB
Neozeo AB Information Technology ServicesTechnology Services Neozeo AB develops blockchain technology. The company is based in Stockholm, Sweden. and has subsidiaries in Latvia. The Swedish company was founded in 2010. The CEO is Petr Vasiliev. | Technology Services |
| Stockholms universitet Inkubator AB | Finance |
TIRmed Pharma AB
TIRmed Pharma AB Pharmaceuticals: MajorHealth Technology TIRmed Pharma AB is engaged in pharmacy services. The company was founded by Jan-Erik Nystroem and Anna-Lena Spetz in 2018 and is headquartered in Bromma, Sweden. | Health Technology |
AB svenska stjärnor
AB svenska stjärnor Investment ManagersFinance AB svenska stjärnor is an asset management company based in Linköping, Sweden. AB svenska stjärnor provides asset management services. The Swedish company was founded in 2018. | Finance |
Redoxis AB
Redoxis AB Medical SpecialtiesHealth Technology Redoxis AB focuses on preclinical drug development and validation in autoimmune diseases. The firm focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The company was founded by David Rikard Martinsson Holmdahl and Jan Peter Olofsson in 2007 and is headquartered in Gothenburg, Sweden. | Health Technology |
